Tim Illidge News Today

EQS-News: Apogenix AG / Key word(s): Scientific publication Apogenix AG: Apogenix’ new CD40 agonist HERA-CD40L significantly reduces tumor growth in prostate cancer model 01.06.2023 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. Apogenix’ new CD40 agonist...

A group of dedicated fundraisers has succeeded in securing £20,000 in donations to contribute to funding breakthrough cancer research

A BROKERS firm in East Lancs has gone all out to make a difference for three causes close to staff members hearts this year.